Variants in the inflammatory IL6 and MPO genes modulate stroke susceptibility through main effects and gene-gene interactions

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 8, 2011, Pages 1751-1759

  Manso, Helena ^a,b,c   Krug, Tiago ^b,d   Sobral, Joo ^a,b,c   Albergaria, Isabel ^a   Gaspar, Gisela ^a   Ferro, José M ^d,e   Oliveira, Sofia A ^b,d   Vicente, Astrid M ^a,b,c  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^e HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Cerebrovascular disease; genetics; inflammation; regeneration and recovery; risk factors

Indexed keywords

INTERLEUKIN 6; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR;

ADULT; AGED; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRINKING; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STROKE; STROKE PATIENT;

AGED; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PEROXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOVERY OF FUNCTION; RISK FACTORS; STROKE;

EID: 79961006752     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2011.27     Document Type: Review

References (38)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-5 (Pubitemid 40202029)
2. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:4-12
3. Bis JC, Heckbert SR, Smith NL, Reiner AP, Rice K, Lumley T, Hindorff LA, Marciante KD, Enquobahrie DA, Monks SA, Psaty BM (2008) Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis 198:166-73 (Pubitemid 351406372)
4. Chung Y, Lee SY, Elston RC, Park T (2007) Odds ratio based multifactor-dimensionality reduction method for detecting gene-gene interactions. Bioinformatics 23: 71-6 (Pubitemid 46017858)
5. Clark WM, Rinker LG, Lessov NS, Hazel K, Eckenstein F (1999) Time course of IL-6 expression in experimental CNS ischemia. Neurol Res 21:287-92 (Pubitemid 29205450)
6. Correale J, Villa A (2004) The neuroprotective role of inflammation in nervous system injuries. J Neurol 251: 1304-16
7. Flex A, Gaetani E, Papaleo P, Straface G, Proia AS, Pecorini G, Tondi P, Pola P, Pola R (2004) Proinflamma-tory genetic profiles in subjects with history of ischemic stroke. Stroke 35:2270-5 (Pubitemid 39311248)
8. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-9 (Pubitemid 34680308)
9. Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508-19 (Pubitemid 43980523)
10. Herrmann O, Tarabin V, Suzuki S, Attigah N, Coserea I, Schneider A, Vogel J, Prinz S, Schwab S, Monyer H, Brombacher F, Schwaninger M (2003) Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab 23:406-15 (Pubitemid 36403022)
11. Hosmer DW, Lemeshow S (2000) Applied Logistic Regression. New York: John Wiley and Sons, Inc
12. Hoy A, Leininger-Muller B, Poirier O, Siest G, Gautier M, Elbaz A, Amarenco P, Visvikis S (2003) Myeloperox-idase polymorphisms in brain infarction. Association with infarct size and functional outcome. Atherosclerosis 167:223-30 (Pubitemid 36775336)
13. Jakulin A, Bratko I (2003) Analyzing attribute interactions. Lect Notes Artif Intell 2838:229-40
14. Krug T, Manso H, Gouveia L, Sobral J, Xavier JM, Albergaria I, Gaspar G, Correia M, Viana-Baptista M, Simões RM, Pinto AN, Taipa R, Ferreira C, Fontes JR, Silva MR, Gabriel JP, Matos I, Lopes G, Ferro JM, Vicente AM, Oliveira SA (2010) Kalirin: a novel genetic risk factor for ischemic stroke. Hum Genet 127:513-23
15. Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7:97
16. Lanktree MB, Dichgans M, Hegele RA (2010) Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41:825-32
17. Lefkowitz DL, Roberts E, Grattendick K, Schwab C, Stuart R, Lincoln J, Allen RC, Moguilevsky N, Bollen A, Lefkowitz SS (2000) The endothelium and cytokine secretion: the role of peroxidases as immunor-egulators. Cell Immunol 202:23-30 (Pubitemid 30445643)
18. Liu J, Sun K, Bai Y, Zhang W, Wang X, Wang Y, Wang H, Chen J, Song X, Xin Y, Liu Z, Hui R (2009) Association of three-gene interaction among MTHFR, ALOX5AP and NOTCH3 with thrombotic stroke: a multicenter case-control study. Hum Genet 125:649-56
19. Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Br J Pharmacol 147(Suppl 1):S232-40 (Pubitemid 43077281)
20. Luheshi G, Rothwell N (1996) Cytokines and fever. Int Arch Allergy Immunol 109:301-7 (Pubitemid 26082836)
21. Manso H, Krug T, Sobral J, Albergaria I, Gaspar G, Ferro JM, Oliveira SA, Vicente AM (2010) Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloprotei-nase-9 genes significantly influence functional outcome after stroke. BMC Med Genet 11:40
22. Mattace Raso F, Rosato M, Talerico A, Cotronei P, Mattace R (1999) Intimal-medial thickness of the common carotid arteries and lower limbs atherosclerosis in the elderly. Minerva Cardioangiol 47:321-7
23. Moore JH (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56:73-82 (Pubitemid 37465073)
24. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, White BC (2006) A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 241:252-61 (Pubitemid 43993963)
25. Moutsopoulos NM, Madianos PN (2006) Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections. Ann NY Acad Sci 1088:251-64 (Pubitemid 47092053)
26. Palmer CN, Kimber CH, Doney AS, Proia AS, Morris AD, Gaetani E, Quarta M, Smith RC, Pola R (2010) Combined effect of inflammatory gene polymorphisms and the risk of ischemic stroke in a prospective cohort of subjects with type 2 diabetes: a Go-DARTS study. Diabetes 59:2945-8
27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-75 (Pubitemid 47330214)
28. Rinaldo A, Bacanu SA, Devlin B, Sonpar V, Wasserman L, Roeder K (2005) Characterization of multilocus linkage disequilibrium. Genet Epidemiol 28:193-206 (Pubitemid 40404574)
29. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138-47 (Pubitemid 32614026)
30. Rodŕguez-Yáñez M, Castillo J (2008) Role of inflammatory markers in brain ischemia. Curr Opin Neurol 21:353-7 (Pubitemid 351653988)
31. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H (2000) Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 101:1372-8 (Pubitemid 30169857)
32. Schindhelm RK, Van der Zwan LP, Teerlink T, Scheffer PG (2009) Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? Clin Chem 55: 1462-70
33. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ (2004) Peak plasma inter-leukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4:2
34. Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, Salaris FS, Arru A, Pirisi A, Rosati G (2006) Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 13:505-13 (Pubitemid 43823367)
35. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158:879-91 (Pubitemid 32221781)
36. Tso AR, Merino JG, Warach S (2007) Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 38:3070-5 (Pubitemid 350035706)
37. Wang Q, Tang XN, Yenari MA (2007) The inflammatory response in stroke. J Neuroimmunol 184:53-68 (Pubitemid 46365991)
38. Yamada Y, Metoki N, Yoshida H, Satoh K, Ichihara S, Kato K, Kameyama T, Yokoi K, Matsuo H, Segawa T, Watanabe S, Nozawa Y (2006) Genetic risk for ischemic and hemorrhagic stroke. Arterioscler Thromb Vasc Biol 26:1920-5 (Pubitemid 44305351)